Daily Women's Health Policy Report Summarizes Research In Breast, Ovarian Cancer

Main Category: Breast Cancer
Also Included In: Ovarian Cancer
Article Date: 06 Aug 2009 - 2:00 PDT

email icon email to a friend   printer icon printer friendly   write icon opinions  

Current Article Ratings:

Patient / Public:not yet rated

Healthcare Prof:not yet rated


The following summarizes recent articles on breast and ovarian cancer research.

~ Breast cancer: For the first time, a large international breast cancer study to determine the effectiveness of radiation therapy after mastectomy will include 200 Chinese women, the New York Times reports. Asian women traditionally have had relatively low breast cancer rates. However, that trend is reversing in China, where breast cancer is on the rise because of rapid urbanization, pollution and diet changes. In addition, China's one-child policy could be contributing to the trend, as breast cancer is less common in women with more children. Chief researcher Ian Kunkler, a professor at the Edinburgh Cancer Research Center, said that although pharmaceutical companies have done clinical trials of chemotherapy drugs in China, "no patient in China has ever been recruited into a randomized controlled trial for breast radiotherapy." Kunkler's trial will include about 3,700 participants overall from Australia, Britain and other parts of Europe, Japan and Singapore (Caryn Rabin, New York Times, 8/3).

~ Ovarian cancer: Two recently published studies have provided new insight into the early stages of ovarian cancer, potentially increasing the likelihood of developing better diagnostic tests, the Wall Street Journal reports. A study published in the journal Nature Genetics has identified a common gene variation called BNC2. Scientists predict that when BNC2 is combined with other gene variations, the result dramatically increases the risk of ovarian cancer. Researchers involved in a study published in the online journal PLoS have determined that ovarian tumors of the BRCA1 mutation exist in the body for about four years before metastasizing but remain less than one centimeter in diameter during that time. They also found that only about half of the tumors grow to be three centimeters in diameter when they do spread (Beck, Wall Street Journal, 8/4).

Reprinted with kind permission from http://www.nationalpartnership.org. You can view the entire Daily Women's Health Policy Report, search the archives, or sign up for email delivery here. The Daily Women's Health Policy Report is a free service of the National Partnership for Women & Families, published by The Advisory Board Company.

© 2009 The Advisory Board Company. All rights reserved.

Article adapted by Medical News Today from original press release.
Visit our breast cancer section for the latest news on this subject.
There are no references listed for this article.
Please use one of the following formats to cite this article in your essay, paper or report:

MLA
National Partnership for Women & Families. "Daily Women's Health Policy Report Summarizes Research In Breast, Ovarian Cancer." Medical News Today. MediLexicon, Intl., 6 Aug. 2009. Web.
13 Feb. 2012. <http://www.medicalnewstoday.com/releases/159960.php>

APA
National Partnership for Women & Families. (2009, August 6). "Daily Women's Health Policy Report Summarizes Research In Breast, Ovarian Cancer." Medical News Today. Retrieved from
http://www.medicalnewstoday.com/releases/159960.php.

Please note: If no author information is provided, the source is cited instead.


Breast Cancer

What Is Breast Cancer?

Breast cancer is a tumor that has become malignant - it has developed from the breast cells. A 'malignant' tumor can spread to other parts of the body - it may also invade surrounding tissue. When it spreads around the body, we call it 'metastasis'. Read more...

Most Popular Articles



Follow Our Breast Cancer News On Twitter

Follow Us On Twitter
Get the latest news for this category delivered straight to your Twitter account. Simply visit our Breast Cancer Twitter account and select the 'follow' option.



View list of all 'What Is...' articles »